India, May 19 -- Marksans Pharma announced that its wholly owned subsidiary Relonchem has received Marketing Authorization for the product Sennosides 7.5 mg Tablets from UK Medicines & Healthcare Products Regulatory Agency.
Published by HT Digital Content Services with permission from Pivotal Sources....